TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 ‐ ALVXM / PEA-PME eligible), a medical device company specializing in spine trauma, today announced that it has reached the key milestone of 25,000 SpineJack® units sold since the market launch of the implant in 2011. This symbolic 25,000 mark in the sales of SpineJack® implants officially occurred in the last […]